Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives

Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt

Standard

Cardiovascular toxicities of radiotherapy : From practical issues to new perspectives. / Aznar, Marianne C.; Bergler-Klein, Jutta; Boriani, Giuseppe; Cutter, David J.; Hurkmans, Coen; Levis, Mario; López-Fernández, Teresa; Lyon, Alexander R.; Maraldo, Maja V.

I: Radiotherapy and Oncology, Bind 197, 110336, 2024.

Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt

Harvard

Aznar, MC, Bergler-Klein, J, Boriani, G, Cutter, DJ, Hurkmans, C, Levis, M, López-Fernández, T, Lyon, AR & Maraldo, MV 2024, 'Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives', Radiotherapy and Oncology, bind 197, 110336. https://doi.org/10.1016/j.radonc.2024.110336

APA

Aznar, M. C., Bergler-Klein, J., Boriani, G., Cutter, D. J., Hurkmans, C., Levis, M., López-Fernández, T., Lyon, A. R., & Maraldo, M. V. (2024). Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives. Radiotherapy and Oncology, 197, [110336]. https://doi.org/10.1016/j.radonc.2024.110336

Vancouver

Aznar MC, Bergler-Klein J, Boriani G, Cutter DJ, Hurkmans C, Levis M o.a. Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives. Radiotherapy and Oncology. 2024;197. 110336. https://doi.org/10.1016/j.radonc.2024.110336

Author

Aznar, Marianne C. ; Bergler-Klein, Jutta ; Boriani, Giuseppe ; Cutter, David J. ; Hurkmans, Coen ; Levis, Mario ; López-Fernández, Teresa ; Lyon, Alexander R. ; Maraldo, Maja V. / Cardiovascular toxicities of radiotherapy : From practical issues to new perspectives. I: Radiotherapy and Oncology. 2024 ; Bind 197.

Bibtex

@article{30ecc16fa3294efcb1d7fcc8998c9904,
title = "Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives",
abstract = "Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.",
author = "Aznar, {Marianne C.} and Jutta Bergler-Klein and Giuseppe Boriani and Cutter, {David J.} and Coen Hurkmans and Mario Levis and Teresa L{\'o}pez-Fern{\'a}ndez and Lyon, {Alexander R.} and Maraldo, {Maja V.}",
year = "2024",
doi = "10.1016/j.radonc.2024.110336",
language = "English",
volume = "197",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Cardiovascular toxicities of radiotherapy

T2 - From practical issues to new perspectives

AU - Aznar, Marianne C.

AU - Bergler-Klein, Jutta

AU - Boriani, Giuseppe

AU - Cutter, David J.

AU - Hurkmans, Coen

AU - Levis, Mario

AU - López-Fernández, Teresa

AU - Lyon, Alexander R.

AU - Maraldo, Maja V.

PY - 2024

Y1 - 2024

N2 - Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.

AB - Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.

U2 - 10.1016/j.radonc.2024.110336

DO - 10.1016/j.radonc.2024.110336

M3 - Editorial

C2 - 38797493

AN - SCOPUS:85195096033

VL - 197

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

M1 - 110336

ER -

ID: 394432683